Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03027557 · OUTCOME

Safety Measures

Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet. · Source last updated 2021-05-25

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Monthly up to one year.

What was measured

Biochemical measures of changes in liver, infection, kidney and electrolyte-status and urinary excretion of calcium.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
description
Biochemical measures of changes in liver, infection, kidney and electrolyte-status and urinary excretion of calcium.
reporting Status
NOT_POSTED
time Frame
Monthly up to one year.
title
Safety Measures
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice